Abstract: In aspects of location based transaction authentication, a mobile device includes a location service to determine a device location of the mobile device. The mobile device also implements a transaction authentication manager that can receive a transaction location of a transaction associated with an account of a user of the mobile device, and compare the device location of the mobile device to the transaction location of the transaction. The transaction authentication manager can also receive a one time password that is masked in response to determining that the device location does not match the transaction location, and reveal the one time password in response to receiving an input on the mobile device to authenticate the transaction.

Abstract: The present invention relates to triterpene derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and ring are as defined herein. The invention also relates to triterpene derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Abstract: A method in a conferencing system terminal device includes detecting, with one or more processors during a videoconference, a communication device electronically in communication with one or more remote electronic devices engaged in the videoconference. One or more processors identify that the videoconference is ending or has ended. The one or more processors determine that an application portal associated with the videoconference is still operational when the videoconference is ending or after the videoconference has ended. The one or more processors present, on a user interface of the conferencing system terminal device, a prompt indicating that the videoconference has ended or is ending when the application portal associated with the videoconference is still operational.

Abstract: A method provides techniques for adjusting a screen position of a moveable display on an electronic device, where the screen position is based on a device state. This enables a user to infer a device state, such as a current volume setting, battery charge level, or other setting, based on a position of the screen while the display is in an off state, enabling conveying of device state information without using any power. The method includes determining an idle state of the electronic device, determining a display state of the electronic device, and determining a device state of the electronic device. The method includes, in response to determining that the device is in an idle state and the display is in an off state, actuating the translation mechanism to translate the blade assembly to a position indicative of the device state of the electronic device.

Abstract: An electronic device, method, and computer program product imitate a typewriter. A top horizontal row of a virtual typing sheet is presented on an upper portion of an extendable display. Keystrokes received by a text input device are monitored and corresponding characters are presented across the top horizontal row of virtual typing sheet. In response to a next line transitioning condition (e.g., reaching an end of a current row or detection of a return keystroke received via the text input device), the extendable display is triggered to upwardly extend by an increment corresponding to vertical dimensions of a line spacing and font size of the characters associated with the top horizontal row. Presentation of the virtual typing sheet and the top horizontal row at the corresponding line spacing are upwardly adjusted to insert a new lateral row for presenting keystrokes.

Abstract: In aspects of rollable screen device voice call management, a mobile device includes a rollable display screen configurable in one of multiple display states corresponding to respective device form factors, such as a compact form factor, an expanded form factor, and a partial form factor. A slidable display mount is operable to extend or retract the rollable display screen into one of the multiple display states corresponding to a device form factor. The mobile device includes an earpiece that emanates audio during a voice call, and the earpiece is integrated with the rollable display screen and/or the slidable display mount. The mobile device implements a configuration manager that initiates the slidable display mount for configuration of the rollable display screen to movably position the earpiece during the voice call, such as relative to a mouthpiece of the mobile device.

Abstract: In aspects of rollable screen simultaneous use, a mobile device includes a rollable display screen configurable in one of multiple display states, including a front-facing portion of the rollable display screen and at least one rear-facing portion of the rollable display screen. The mobile device implements a configuration manager that adjusts content displayed for viewing on the front-facing portion of the rollable display screen based at least in part on a touch actuation to a selectable control on the rear-facing portion of the rollable display screen.

Abstract: The present invention relates to novel triterpene derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, n, and ring are as defined in formula (I). The invention also relates to novel triterpene derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Abstract: A device receives an electronic communication from another device, such as an email. The communication is addressed to multiple recipients and the device determines an association of content in the communication to a user of the device. This association of content to a user can be determined in various manners, such as by identifying one of multiple portions of the communication that is directed to the user rather than other recipients of the communication, determining whether the user is a primary recipient or a secondary recipient of the communication, and so forth. The device generates a set of natural language responses to the communication for the user based at least in part on this association. The device displays the set of natural language responses and receives user selection of one of the natural language responses, then sends the selected natural language response to at least the other device.

Abstract: The present invention relates to novel triterpene derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and ring are as defined herein. The invention also relates to novel triterpene derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Abstract: The present invention relates to novel triterpenone derivatives of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined herein. The invention also relates to novel triterpenone derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Abstract: A device receives an electronic communication from another device, such as an email. The communication is addressed to multiple recipients and the device determines an association of content in the communication to a user of the device. This association of content to a user can be determined in various manners, such as by identifying one of multiple portions of the communication that is directed to the user rather than other recipients of the communication, determining whether the user is a primary recipient or a secondary recipient of the communication, and so forth. The device generates a set of natural language responses to the communication for the user based at least in part on this association. The device displays the set of natural language responses and receives user selection of one of the natural language responses, then sends the selected natural language response to at least the other device.

Abstract: The invention relates to C-3 novel triterpenone with C-17 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Abstract: The present invention relates to C-3 novel triterpenone with C-28 urea derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, compositions or combination thereof, wherein R1, R2, R3, W, J and X are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the treatment of viral diseases and particularly HIV mediated diseases.

Abstract: The invention relates to C-3 novel triterpenone with C-17 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Abstract: The invention relates to C-3 novel triterpenone with C-17 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

Abstract: The invention relates to C-3 novel triterpenone with C-28 amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases (formula 1).

Abstract: The present invention relates to C-3 novel triterpenone with C-28 urea derivatives of formula (I); or pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutically acceptable hydrates, tautomers, stereoisomers, prodrugs, compositions or combination thereof, wherein R1, R2, R3, W, J and X are as defined herein. The present invention also relates to pharmaceutical compositions comprising compounds of formula (I) useful for the treatment of viral diseases and particularly HIV mediated diseases.

Abstract: The invention relates to C-3 novel triterpenone with C-28 amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases (formula 1).

Abstract: Formula (I) The invention relates to C-3 novel triterpenone with C-28 reverse amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.